IMMUNOVO
Immunovo BV is a Dutch private biotechnology company, based in ‘s-Hertogenbosch, engaged in the discovery and clinical development of immunotherapeutics in the field of oncology. The key priority for Immunovo is on its proprietary Immune Activation System (IAS) based on combining synthetic peptide antigens with a novel immune stimulant (adjuvant).
IMMUNOVO
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
's-hertogenbosch, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.immunovo.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0) 73 – 627 4520
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Facebook Sharer OpenResty AdBlock Acceptable Ads Sharktech Shark Tech
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Employees Featured
Investors List
Biox Biosciences
Biox Biosciences investment in Seed Round - Immunovo
Lupus Ventures
Lupus Ventures investment in Seed Round - Immunovo
Official Site Inspections
http://www.immunovo.com
- Host name: 154.220.94.157
- IP address: 154.220.94.157
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
